Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells

9 Jan 2018

Abstract excerpt

// Sergey V. Kulemzin 1, * , Andrey A. Gorchakov 1, 2, * , Anton N. Chikaev 1 , Valeriya V. Kuznetsova 1 , Olga Y. Volkova 1 , Daria A. Matvienko 1, 2 , Alexey V. Petukhov 3 , Andrey Y. Zaritskey 3 and Alexandr V. Taranin 1, 2 1 Institute of Molecular and Cellular Biology SB RAS, Novosibirsk, Russia 2 Novosibirsk State University, Novosibirsk, Russia 3 Institute of Hematology, Almazov National Medical Research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immune Cell Function and Interaction
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29507671
DOI: 10.18632/oncotarget.24078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cellsPMID 29507671Read ↗

Construction and characterization of chimeric FcγR T cells for universal T cell therapySemantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challengesSemantic proximity Read ↗

NK Cells Armed with Chimeric Antigen Receptors (CAR): Roadblocks to Successful DevelopmentSemantic proximity Read ↗

Chimeric Antigen Receptors: A Paradigm Shift in ImmunotherapySemantic proximity Read ↗

Chimeric antigen receptor-natural killer cell therapy: a new force in intrinsic immunotherapy for cancer treatmentSemantic proximity Read ↗

Building Better Chimeric Antigen Receptors for Adoptive T Cell TherapySemantic proximity Read ↗

NK cells specifically TCR-dressed to kill cancer cellsSemantic proximity Read ↗

Nanobody-based CAR-T cells for cancer immunotherapySemantic proximity Read ↗

Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospectsSemantic proximity Read ↗

A CHIMERIC RECEPTOR ENABLING ANTIBODY-GUIDED RETARGETING OF CAR T- CELLSSemantic proximity Read ↗

Current status and perspective of CAR-T and CAR-NK cell therapy trials in GermanySemantic proximity Read ↗

A structural, genetic and clinical comparison of CAR-T cells and CAR-NK cells: companions or competitors?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.